Panmure Gordon (UK) Limited, an exempt principal trader, has disclosed its dealings in the securities of Allergy Therapeutics plc. On August 8, 2023, Panmure Gordon purchased 285,659 0.1p ordinary shares at a price range of 0.031p to 0.0332p per unit. They also sold 322,358 0.1p ordinary shares at a price range of 0.033p to 0.036p per unit. No cash-settled derivative transactions or stock-settled derivative transactions were reported. No indemnity or option arrangements, agreements, or understandings were disclosed. The disclosure was made in accordance with Rule 8 of the Takeover Code.